Chargement en cours...

Clinical trial of sparfloxacin for lepromatous leprosy.

Nine previously untreated patients with lepromatous leprosy were treated with 200 mg of sparfloxacin daily for 12 weeks to determine whether this drug is bactericidal for Mycobacterium leprae in humans. The efficacy of therapy was monitored both clinically and by measuring changes in morphological i...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chan, G P, Garcia-Ignacio, B Y, Chavez, V E, Livelo, J B, Jimenez, C L, Parrilla, M L, Franzblau, S G
Format: Artigo
Langue:Inglês
Publié: 1994
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC284397/
https://ncbi.nlm.nih.gov/pubmed/8141581
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!